Tonix Pharmaceuticals Holding Corp (TNXP)
R&D Expense Growth
6.61%
Quarterly · Period ending:
TNXP R&D Expense Growth
Latest reported6.61%period ending
Latest reported6.61%period ending
TNXP Quarterly R&D Growth (QoQ) (0.00% → 6.61%)
Latest values, visible window
High-resolution chart · PNG
TNXP r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 6.6107% | |
| 7.5084% | |
| 82.377% | |
| -14.1497% | |
| 45.5083% | |
| -10.3772% | |
| -8.9642% | |
| -6.0219% | |
| -24.6055% | |
| -24.8657% | |
| -18.6698% | |
| -4.2137% | |
| -17.1061% | |
| 7.4451% | |
| 11.1391% | |
| 33.9104% | |
| -10.0043% | |
| -17.3753% | |
| 70.4327% | |
| -27.8553% | |
| 18.3076% | |
| 26.7008% | |
| 37.2631% | |
| -16.6304% | |
| 126.0693% | |
| -17.8207% | |
| 12.6287% | |
| 42.1497% | |
| -8.7782% | |
| -22.9583% | |
| 54.9326% | |
| -19.7443% | |
| -21.3346% | |
| 42.2675% | |
| -7.0113% | |
| 39.273% | |
| -6.2792% | |
| -38.635% | |
| -10.7391% | |
| -27.2751% | |
| -29.5661% | |
| 12.4447% | |
| -7.9891% | |
| 16.2665% | |
| 29.9019% | |
| 18.2511% | |
| 10.6958% | |
| 28.0245% | |
| 14.7887% | |
| 167.3193% | |
| -18.8674% | |
| 73.3936% | |
| 27.4586% | |
| 5.8421% | |
| 6.3217% | |
| -20.4938% | |
| 108.1815% | |
| -65.6675% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |